Oral forodesine (Bcx-1777) is clinically active in refractory cutaneous T-cell lymphoma: Results of a phase I/II study. Duvic, M., Forero-Torres, A., Foss, F., Olsen, E. A., Kim, Y. AMER SOC HEMATOLOGY. 2006: 698A

View details for Web of Science ID 000242440003257